Person: ERENBERK, UFUK
Search Results
Altı Aylık Çocuk Hastada Asemptomatik Çift Aortik Ark
2019-04-14, OTCU H., YAKUT K., UZUNER S., USTABAŞ KAHRAMAN F., ERENBERK U., YOZGAT Y., OTÇU TEMUR, HAFİZE, UZUNER, SELÇUK, USTABAŞ KAHRAMAN, FEYZA, ERENBERK, UFUK, YOZGAT, YILMAZ
Human Paraoxonase-1 Activity in Children with Acute Bronchiolitis
2020-03-01, ERENBERK U., USTABAŞ KAHRAMAN F., ÖZKAYA E., NURSOY M. A., DOĞAN DEMİR A., TÜREL Ö., ERENBERK, UFUK, USTABAŞ KAHRAMAN, FEYZA, NURSOY, MUSTAFA ATİLLA, DOĞAN DEMİR, AYŞEGÜL, TÜREL, ÖZDEN
INTRODUCTION: Human paraoxonase-1 (PON1) is one of the endogenous antioxidant molecules working against oxidative stress. We aimed to investigate serum PON1 activity in children with acute bronchiolitis.
İnferior Vena Kava Tipi Sinus Venosus ASD›li Yedi Yaşındaki Hastanın TEE Görüntüleri
2019-04-14, YAKUT K., OTCU H., UZUNER S., USTABAŞ KAHRAMAN F., ERENBERK U., YOZGAT Y., OTÇU TEMUR, HAFİZE, UZUNER, SELÇUK, USTABAŞ KAHRAMAN, FEYZA, ERENBERK, UFUK, YOZGAT, YILMAZ
Oxidative and antioxidative status of children with acute bronchiolitis
2013-07-01T00:00:00Z, Dundaroz, Rusen, Erenberk, Ufuk, Turel, Ozden, Demir, Aysegul Dogan, Ozkaya, Emin, Erel, Ozcan, ERENBERK, UFUK
Objective: Oxidative stress has been shown to contribute to the pathogenesis of acute and chronic lung inflammatory diseases. This article aimed to evaluate the oxidant/antioxidant status of children with acute bronchiolitis through the measurement of plasma total antioxidant capacity, total oxidant status, and oxidative stress index.
Kawasaki Hastalığına Bağlı Dev Sağ Koroner Arter Dilatasyonu Gelişen 13 Yaşındaki Erkek Hastada Üç Yıl Kumadin Tedavisi Sonrası Tam Düzelme
2018-04-21, YOZGAT Y., YAKUT K., OTCU H., ERENBERK U., UZUNER S., USTABAŞ KAHRAMAN F., YOZGAT, YILMAZ, OTÇU TEMUR, HAFİZE, ERENBERK, UFUK, UZUNER, SELÇUK, USTABAŞ KAHRAMAN, FEYZA
Short-term azithromycin use is associated with QTc interval prolongation in children with cystic fibrosis
2024-01-01, Enhoş A., Doğuş Kus H., Yozgat C. Y., Cakır E., Yazan H., Erol A. B., ERENBERK U., YOZGAT Y., ENHOŞ, ASIM, ÇAKIR, ERKAN, YAZAN, HAKAN, ERENBERK, UFUK
Background: Azithromycin is used for children with cystic fibrosis (CF) for its immunomodulatory and anti-inflammatory action. This study investigated the short-term alterations in QTc interval associated with azithromycin prophylaxis in pediatric patients with CF. Methods: This study included 121 patients with mild CF, of whom 76 received azithromycin (patient group) and 45 did not receive azithromycin (control group). The patient and control groups were categorized according to age as under 12 years of age and over 12 years of age. The first presentation measured all the patient and control groups at basic QTc time intervals. The QTc intervals of all patients were then remeasured systemically at 1, 3, and 6 months. Age categories and QTc intervals that were calculated at each month in the patient and control groups were compared statistically. Results: A statistically significant difference was detected in the patient group between the initial QTc interval time and the electrocardiogram (ECG) findings in the first and third months after prophylaxis treatment (p 0.05) in all groups. Almost all of the children\"s QTc intervals were within normal range and within the safety zone (under 0.44 s). No statistically significant difference was detected in the control group between the initial ECG and the QTc intervals measured at 1, 3, and 6 months. Conclusion: Short-term use of azithromycin prophylaxis in pediatric patients with mild CF slightly increased the QTc interval in the first and third months of follow-up. Nevertheless, all QTc interval changes fell within the safety zone. Notably, 1 month of follow-up treatment should be performed to check for any alteration in the QTc interval. If increased QTc interval duration is not detected in the first month, azithromycin prophylaxis can be safely prescribed.